PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33969374-0	2021	LncRNA UCA1 elevates the resistance of human leukaemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613.	Daunorubicin	64-76	urothelial cancer associated 1	Homo sapiens	7-11	
33969374-9	2021	DNR constrained viability, cell cycle progression, invasion, and facilitated apoptosis of HL-60 and U-937 cells in a dose-dependent manner, but these impacts mediated by DNR were reverted after UCA1 overexpression.	Daunorubicin	170-173	urothelial cancer associated 1	Homo sapiens	194-198	
33969374-11	2021	MiR-613 inhibitor reversed DNR treatment-mediated effects on viability, cell cycle progression, apoptosis, and invasion of HL-60 and U-937 cells, but these impacts mediated by miR-613 inhibitor were counteracted after UCA1 inhibition.	Daunorubicin	27-30	urothelial cancer associated 1	Homo sapiens	218-222	
33969374-13	2021	In conclusion, UCA1 upregulation facilitated the resistance of acute leukemia cells to DNR via the PI3K/AKT pathway by sponging miR-613.	Daunorubicin	87-90	urothelial cancer associated 1	Homo sapiens	15-19	
33969374-9	2021	DNR constrained viability, cell cycle progression, invasion, and facilitated apoptosis of HL-60 and U-937 cells in a dose-dependent manner, but these impacts mediated by DNR were reverted after UCA1 overexpression.	Daunorubicin	0-3	urothelial cancer associated 1	Homo sapiens	194-198